O Brien Greene & Co. Inc Invests $572,000 in Amrize Ltd $AMRZ

O Brien Greene & Co. Inc acquired a new position in shares of Amrize Ltd (NYSE:AMRZ) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 10,581 shares of the company’s stock, valued at approximately $572,000.

Several other large investors have also modified their holdings of the stock. Geode Capital Management LLC acquired a new stake in Amrize during the 2nd quarter worth approximately $265,000. M&T Bank Corp acquired a new stake in Amrize in the second quarter valued at approximately $205,000. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Amrize during the second quarter worth approximately $3,870,000. Gabelli Funds LLC acquired a new stake in shares of Amrize during the second quarter worth approximately $1,083,000. Finally, AXA S.A. acquired a new position in Amrize in the second quarter worth $1,065,000.

Wall Street Analyst Weigh In

AMRZ has been the topic of a number of recent research reports. Vertical Research upgraded Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price on the stock in a research note on Friday, May 1st. Wall Street Zen upgraded Amrize from a “sell” rating to a “hold” rating in a research note on Sunday, March 1st. Berenberg Bank set a $70.00 target price on Amrize in a research note on Thursday, February 19th. Royal Bank Of Canada cut their target price on Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $65.00 target price on shares of Amrize in a research note on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Amrize presently has an average rating of “Moderate Buy” and a consensus target price of $64.50.

Amrize Price Performance

Shares of NYSE AMRZ opened at $48.98 on Friday. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The firm’s 50-day simple moving average is $55.74 and its 200 day simple moving average is $55.14. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. The stock has a market cap of $27.09 billion and a P/E ratio of 23.44.

Amrize (NYSE:AMRZ) last issued its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company had revenue of $2.18 billion for the quarter. The company’s revenue was up 4.7% compared to the same quarter last year. Equities analysts expect that Amrize Ltd will post 2.7 EPS for the current year.

Amrize Cuts Dividend

The company also recently announced a dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be issued a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, May 12th. Amrize’s payout ratio is presently 21.05%.

Insider Activity

In other news, CTO Roald Brouwer bought 3,000 shares of the stock in a transaction that occurred on Wednesday, March 11th. The shares were purchased at an average cost of $58.72 per share, with a total value of $176,160.00. Following the completion of the acquisition, the chief technology officer directly owned 16,257 shares in the company, valued at approximately $954,611.04. The trade was a 22.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mario Gross purchased 3,200 shares of the company’s stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average cost of $55.29 per share, for a total transaction of $176,928.00. Following the purchase, the insider directly owned 30,947 shares in the company, valued at $1,711,059.63. This represents a 11.53% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired 77,836 shares of company stock valued at $4,511,449 over the last quarter. Insiders own 0.54% of the company’s stock.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.